Skyrizi

Skyrizi (risankizumab) is a prescription medication used for moderate to severe plaque psoriasis and psoriatic arthritis. It belongs to the class of biologics, working to reduce inflammation. Always consult a healthcare provider before use.

Skyrizi is primarily used to treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. It is also approved for active psoriatic arthritis, helping to reduce joint pain and skin symptoms. Patients often ask, 'what is Skyrizi used for?' as it targets immune system pathways to improve skin and joint health.

Skyrizi works by targeting specific proteins in the immune system to reduce inflammation and skin cell overgrowth. Users may notice gradual improvements in skin appearance and joint comfort over time. The effects vary by individual, and consistent use is important for best results.

Skyrizi is for subcutaneous use only and should be handled with care to avoid contamination or infection. Keep the medication refrigerated but do not freeze. Always follow your healthcare provider’s instructions for storage and disposal. Inform your doctor of any active infections before starting treatment.

Skyrizi may interact with other biologics or immunosuppressants, increasing infection risk. Live vaccines should be avoided during treatment. Discuss all medications, including over-the-counter and herbal products, with your healthcare provider. Alcohol use may not directly interact but can affect overall health during therapy.